Corridome

SomaLogic

Sale Life Sciences & Pharma June 23, 2025

From an SEC filing dated Jun 23, 2025

  1. SomaLogic agreed to be sold to Illumina, announced on Jun 23, 2025.

    8-K

  2. Centerview Partnersfirm and UBS Securitiesfirm advised the seller.

    8-K

  3. Goldman Sachs & Co.firm advised the buyer.

    8-K

  4. The filing puts the value at $425M.

    8-K

  5. Centerview Partnersfirm also worked on Maplebear Incdeal, on Oct 29, 2026.

    8-K

At a glance

Who was on each side

SellerStandard BioTools

Seller's adviserCenterview Partners

Seller's adviserUBS Securities

The companySomaLogic$425Maggregate considerationJun 23, 2025

BuyerIllumina

Buyer's adviserGoldman Sachs & Co.

Each party is named in the sources beside the statement

Parties

first 2 of 5

PartyRoleSource
IlluminaBuyer8-K
Standard BioToolsSeller8-K

3 more parties

Sign up free to see all 5.

Sign up free

Value

KindAmountBasisSource
Price$425Maggregate consideration8-K

More deals

first 2 of 14

DateDealFirmsSource
Oct 29, 2026ADT Inc · SaleThrive Capital, Citigroup Global Markets8-K
Oct 29, 2026Maplebear Inc · SaleGoldman Sachs & Co., Centerview Partners8-K

12 more deals

Deals with Centerview Partners, UBS Securities and Goldman Sachs & Co..

Sign up free to see the first 5, or become a member to see all 14.

Sign up freeBecome a member

On file

Date as stated
June 23, 20258-K
Filed by
Standard Biotools Inc. (LAB)8-K
Status
Announced8-K

Browse the database